This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, New York


OrbiMed was established in 1989, and is a well known VC. The VC's location is in North America, United States. The the headquarters of this VC is in New York.

The fund typically invests in rounds with 5-6 participants. Besides OrbiMed, start-ups are typically funded by New Enterprise Associates, Kearny Venture Partners, Sequoia Capital and 195 more VCs. Other VCs who often invest in the same rounds are Deerfield, Alta Partners, Topspin Partners, the total number of co-investors is 243. The investors in the following rounds are usually Versant Ventures, Venrock, OUP (Osage University Partners), and 168 VCs in total.

Besides the listed founders, we have found 15 key employees of this fund in our database.

At the time of investment by OrbiMed, a typical start-up valuation would be 100-500 millions dollars. The most exits for the fund occurred in 2015. In terms of the fund's performance, this VC has 22 percentage points more exits when compared to other organizations. The most common rounds for this fund are in the range of 10 - 50 millions dollars. In 2017, the fund's activity was at its peak. In addition, the fund was active in 2019. OrbiMed is involved in 6 percentage points more than the average amount of lead investments when compared with other funds. The fund generally invests in 13-24 deals every year.

The country of its establishment and the country of its most frequent investments coincides - United States. However, start-ups from 13 other countries can be found in the fund's portfolio. Also, a start-up has to be aged 6-10 years to expect investment from this fund. Among the most popular investment industries for the fund are Biotechnology, Clinical Trials. However, the fund’s focus is not limited to this, since there are 20 more areas of investment. Among the most popular portfolio start-ups of the fund, are Loxo Oncology, Receptos, Avanir Pharmaceuticals. The fund has an exact preference in the amount of founders of companies in its portfolio. If there are 5+ founders in the start-up, the probability of getting the investment is low.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: orbimed.com; User name format in descending order of probability: first last_initial, last first_initial

Group Appearance [how often fund is operating separately from groups with shared interest]

97.3% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

30.2% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

3 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.65 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Funds Investing Together

Deerfield, Alta Partners, Topspin Partners

Funds Investing in Following

Versant Ventures, Venrock, OUP (Osage University Partners)

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: